| December 31, 201 7 | December 31, 201 6 | |||||||
| Current: | ||||||||
| Federal | $ | (702 | ) | $ | (39 | ) | ||
| State | 1 | 6 | ||||||
| Total Current | (701 | ) | (33 | ) | ||||
| Deferred: | ||||||||
| Federal | — | (1 | ) | |||||
| State | — | — | ||||||
| Total D eferred | — | (1 | ) | |||||
| Provision (benefit) for income taxes | $ | (701 | ) | $ | (34 | ) | ||
| December 31, 201 7 | December 31, 201 6 | |||||||
| Deferred tax assets: | ||||||||
| Accruals and other | $ | 2,717 | $ | 3,746 | ||||
| Research credits | 6,530 | 5,670 | ||||||
| Net operating loss carryforward | 31,064 | 36,224 | ||||||
| Section 59(e) R&D expenditures | 12,156 | 16,782 | ||||||
| Deferred revenue | 18,384 | 24,836 | ||||||
| AMT credit | — | 703 | ||||||
| Total deferred tax assets | 70,851 | 87,961 | ||||||
| Valuation allowance | (70,851 | ) | (87,961 | ) | ||||
| Net deferred tax assets | $ | — | $ | — | ||||
| Year Ended December 31, | ||||||||||||
| 201 7 | 2016 | 2015 | ||||||||||
| Tax at statutory federal rate | $ | (17,751 | ) | $ | (14,685 | ) | $ | (8,037 | ) | |||
| State tax —net of federal benefit | 350 | (73 | ) | 2,853 | ||||||||
| PIPE Warrant liability | (70 | ) | (260 | ) | (726 | ) | ||||||
| General Business credits | (316 | ) | (360 | ) | (455 | ) | ||||||
| Stock Options | 42 | 1,115 | 1,559 | |||||||||
| Other | 51 | 33 | 73 | |||||||||
| Change in valuation allowance | (17,110 | ) | 14,196 | 5,493 | ||||||||
| Tax Reform – Tax Rate Change | 34,103 | — | — | |||||||||
| Provision for income taxes | $ | (701 | ) | $ | (34 | ) | $ | 760 | ||||
| Year Ended December 31, | ||||||||||||
| 2017 | 2016 | 2015 | ||||||||||
| Unrecognized benefit —beginning of period | $ | 2,162 | $ | 1,939 | $ | 1,667 | ||||||
| Gross decreases —prior period tax positions | — | — | — | |||||||||
| Gross increases —current period tax positions | 203 | 223 | 272 | |||||||||
| Unrecognized benefit —end of period | $ | 2,365 | $ | 2,162 | $ | 1,939 | ||||||